Risk of infective endocarditis in oncohaematological patients undergoing active treatment with Enterococcus faecalis bloodstream infection: A retrospective multicentre study
Systematic IE screening may not be warranted in this population and should instead be individualised on the basis of clinical risk factors.
Authors
- Anna Falcó-Roget (ORCID: https://orcid.org/0009-0003-1774-679X)
- Júlia Laporte-Amargós (ORCID: https://orcid.org/0000-0001-6114-7231)
- Belen Viñado-Pérez
- Núria Fernández-Hidalgo (ORCID: https://orcid.org/0000-0002-2115-344X)
- Laura Escolà‐Vergé (ORCID: https://orcid.org/0000-0002-5608-3090)
- Sara Grillo (ORCID: https://orcid.org/0000-0002-3596-8690)
- Miguel Perez
- Laura Camps-Relats
- Alexander Rombauts (ORCID: https://orcid.org/0000-0003-0227-5916)
- María Alba Rivera Martínez
- Joaquín López-Contreras
- Alba Bergas
- Adaia Albasanz-Puig
Institutions
- Universitat Autònoma de Barcelona (ES)
- Hospital de Sant Pau (ES)
- Bellvitge University Hospital (ES)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Vall d'Hebron Institut de Recerca (ES)
- Institut Català d'Oncologia (ES)
- Vall d'Hebron Hospital Universitari (ES)
Publication Details
- Journal
- International Journal of Antimicrobial Agents
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1016/j.ijantimicag.2025.107706
- Primary Topic
- Infective Endocarditis Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00